Add BrightSurf on Google Email

Johns Hopkins Medicine


Drug therapy for PKU reverses heart damage

Researchers found that treatment with BH4 stabilizes the pumping function of failing hearts and dramatically shrinks muscle size in a short timeframe. The study's findings offer proof of principle that damage to the heart can be stopped and reversed, providing a potential therapy for high blood pressure.

SourceJohns Hopkins Medicine·JournalCirculation·DateMay 13, 2008

Hopkins researchers discover new link to schizophrenia

Researchers at Johns Hopkins have discovered a link between the BACE1 enzyme and schizophrenia-like behaviors in mice lacking this enzyme. The study found that these mice exhibited deficits in social recognition and other schizophrenia-like traits, which improved with treatment with antipsychotic drug clozapine.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateMay 8, 2008

Clinical trial volunteers mostly indifferent -- but not blind to -- researchers' financial conflicts

A new study found that potential research participants are mostly indifferent to financial disclosures from researchers, but trust decreases when the researcher owns company stock. The study suggests that clearer guidelines for disclosing acceptable financial interests are needed to inform potential study participants.

SourceJohns Hopkins Medicine·JournalJournal of General Internal Medicine·DateApr 4, 2008

'Lab on a chip' mimics brain chemistry

Scientists develop micro-scale tool to study how nerve cells in the brain work together, providing insights into growth and signaling molecules. The 'lab on a chip' system helps researchers understand complex interactions between neurons and their environment.

SourceJohns Hopkins Medicine·JournalLab on a Chip·DateFeb 12, 2008

Downsized heart aids bypass surgery

A new study found that combining coronary artery bypass grafting (CABG) with surgical ventricular restoration (SVR) reduces the likelihood of subsequent heart problems by 24%, compared to 55% for CABG alone. SVR improves heart function, enabling patients to stay active and participate in daily activities without exhaustion.

Ways to improve informed consent are testable, study says

A new questionnaire tool was developed to assess the informed consent process in clinical trials. The tool aimed to educate potential participants on the risks and benefits of taking part in research. However, the results showed that the tool did not improve informed consent in this experiment. Despite this, the study's findings provid...

SourceJohns Hopkins Medicine·JournalClinical Trials·DateJan 11, 2008

Gene dose affects tumor growth

Researchers found that extra copies of a particular gene can repress tumor growth, while missing a copy enhances tumor growth. Mice with three copies of the gene had fewer tumors than those with two copies, while mice with one copy developed more tumors.

SourceJohns Hopkins Medicine·JournalNature·DateJan 3, 2008

'Swish-and-spit' test accurate for cancer

Scientists at Johns Hopkins Kimmel Cancer Center have developed a new saliva test that accurately detects head and neck cancer in 42.9% of patients, ruling out the disease in 81.9% of healthy individuals. The test uses genetic signatures common to the disease and holds promise for screening high-risk populations.

SourceJohns Hopkins Medicine·JournalClinical Cancer Research·DateJan 1, 2008

More 'functional' DNA in genome than previously thought

A team of researchers has found that current computer programs can miss up to 60% of regulatory DNA regions, which contribute to inherited diseases like Parkinson's and mental disorders. The study used a novel approach to identify functional DNA sequences in zebrafish embryos, uncovering 17 discrete DNA segments with regulatory potential.

SourceJohns Hopkins Medicine·JournalGenome Research·DateDec 11, 2007

Keeping at-risk cells from developing cancer

Scientists at Johns Hopkins Medicine discovered that epigenetic changes in gene activation can lead to cancer development, and found a way to block the 'addiction' to growth factors, preventing cancer growth. The study shows that blocking this response can greatly reduce precancerous lesions in animals.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateDec 10, 2007

Silencing small but mighty cancer inhibitors

A research team has discovered that the Myc protein can suppress the production of at least 13 microRNAs in cancer cells. Reintroducing these repressed miRNAs into Myc-containing cancer cells suppressed tumor growth in mice, suggesting a potential gene therapy approach for certain cancers.

SourceJohns Hopkins Medicine·JournalNature Genetics·DateDec 10, 2007

Adult brain cells are movers and shakers

A study by Johns Hopkins Medicine reveals a subset of adult brain cells that can exhibit dynamic behavior, including elongation and morphing, unlike traditional adult axons. This discovery opens up new avenues for understanding neural recovery following stroke or other brain trauma.

SourceJohns Hopkins Medicine·JournalNeuron·DateNov 8, 2007